Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 8.1 EX-8.1 - Opinion of Foley Hoag Relating to Tax Matters
- 8.2 EX-8.2 - Opinion of Wilson Sonsini Goodrich & Rosati, PC Relating to Tax Matters
- 23.1 EX-23.1 - Consent of Bdo Seidman, LLP Re: Inverness' Financials
- 23.2 EX-23.2 - Consent of Pricewaterhousecoopers LLP Re: Hemosense's Financials
- 23.3 EX-23.3 - Consent of Pricewaterhousecoopers LLP Re: Cholestech's Financials
- 23.4 EX-23.4 - Consent of Ernst & Young LLP Re: Biosite's Financials
- 23.5 EX-23.5 - Consent of Colby & Company, PLC Re: Instant's Financials
- 99.3 EX-99.3 - Consent of Lazard Freres & Co., LLC
- 99.4 EX-99.4 - Form of Proxy of Hemosense
Alere similar filings
- 12 Feb 10 Registration of securities issued in business combination transactions
- 14 Feb 08 Registration of securities issued in business combination transactions
- 23 Oct 07 Registration of securities issued in business combination transactions
- 5 Oct 07 Registration of securities issued in business combination transactions (amended)
- 6 Sep 07 Registration of securities issued in business combination transactions
- 20 Jul 07 Registration of securities issued in business combination transactions
- 9 Feb 05 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.4
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 23, 2007, with respect to the consolidated financial statements of Biosite Incorporated, incorporated by reference in the Current Report on Form 8-K of Inverness Medical Innovations, Inc., filed with the Securities and Exchange Commission on July 2, 2007, as amended on July 20, 2007, and incorporated by reference in the proxy statement/prospectus of Inverness Medical Innovations, Inc. that is made a part of this Amendment No. 1 to the Registration Statement on Form S-4/A (No. 333-145892).
/s/ Ernst & Young LLP | ||||
San Diego, California
October 4, 2007